Business · 23/04/2008Updated: 10/17/2026 · 1 min read
FDA Approves Enrofloxacin for Swine Respiratory Disease Treatment
Summary
The FDA is updating its animal drug regulations to include approval for Bayer HealthCare's enrofloxacin injectable solution to treat respiratory disease in swine, following the submission of a supplemental new animal drug application (NADA).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →